Secretome Therapeutics is currently preparing an open-label, multiple ascending dose phase 1 study to assess STM-01 in patients with HFpEF. The Food and Drug Administration (FDA) has granted Fast ...
HUNTINGTON, W.Va. (WSAZ) - Newborn babies who were exposed to drugs during pregnancy require special care in the nursery. Dr. Jodi Plumley, a Marshall Health pediatrician and medical director of the ...
"Overall, the meta-analysis positions intermittent blue light therapy as a valuable option in the clinical management of ...
Neonatal respiratory distress syndrome (RDS) remains a leading cause of morbidity and mortality in preterm infants. This condition stems primarily from an insufficiency in pulmonary surfactant, a ...
Background: The extensive use of broad-spectrum antibiotics has been associated with major changes in the spectrum of organisms involved in early-onset neonatal infection (EONI), their susceptibility ...
PHILADELPHIA, January 07, 2026--(BUSINESS WIRE)--iECURE, Inc., a genome editing company focused on the development of variant-agnostic in vivo targeted gene insertion therapies for the treatment of ...
National Association of Neonatal Therapists is hosting their annual conference, NANT 14 – Champions of Neonatal Development from April 12-13, 2024, with pre-conference workshops and welcome reception ...
CINCINNATI, OHIO, UNITED STATES, September 16, 2024 / EINPresswire.com / -- The National Association of Neonatal Therapists (NANT) is thrilled to announce the upcoming International Neonatal Therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results